Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
84.27
-2.54 (-2.93%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Arcellx Market Cap
Arcellx has a market cap or net worth of $4.53 billion as of October 31, 2024. Its market cap has increased by 166.42% in one year.
Market Cap
4.53B
Enterprise Value
3.96B
1-Year Change
166.42%
Ranking
Category
Stock Price
$84.27
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $4.53B, an increase of 800.32%. That is a compound annual growth rate of 123.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 4.67B | 72.70% |
| Dec 29, 2023 | 2.70B | 98.89% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acadia Healthcare Company | 4.78B |
| PROCEPT BioRobotics | 4.73B |
| Madrigal Pharmaceuticals | 4.71B |
| Waystar Holding | 4.65B |
| BridgeBio Pharma | 4.60B |
| Organon & Co. | 4.50B |
| Sotera Health Company | 4.48B |
| CRISPR Therapeutics AG | 4.40B |